160 Health International Limited (02656) disclosed a monthly return for February 2026, indicating that its authorized share capital remained at 25,000,000,000 ordinary shares, each with a par value of USD 0.000002, totaling USD 50,000. There was no increase or decrease in this authorized share capital during the reporting period.

As of the end of February 2026, the number of issued shares stood at 336,452,810, with no treasury shares reported. The company confirmed compliance with the 25% public float requirement. Meanwhile, under its Pre-IPO Share Option Scheme, 31,184,585 share options were outstanding with no changes in issued shares during the month. Of these options, 14,487,990 shares may be issued upon exercise.

No other movements involving warrants, convertibles, or treasury shares were recorded in February 2026, and no new shares were issued or cancelled. The company stated that all applicable requirements, including regulatory and listing obligations, were duly fulfilled during the period.